These 4 Big Cap Health Care Stocks Just Hit New 52-Week Lows
The health care sector is likely reacting to the uncertainty created by the effect of federal budget cuts now being ...
Reuters6d
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
Moderna reports larger-than-expected quarterly loss Revenue falls 66% but beats expectations FDA pauses norovirus vaccine trial after adverse event report Feb 14 (Reuters) - Moderna (MRNA.O ...
Yahoo Finance6d
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
(Reuters) -Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare neurological side effect was reported. The trial of the ...
Wall Street Journal6d
Moderna Stock Rebounds Despite Vaccine Maker's Wider-Than-Expected Loss
Moderna shares recovered from an early dip premarket despite the biotech's quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion ...
MarketWatch6d
Moderna Swings to 4Q Loss After Early Launch of Updated Vaccine
Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter. The maker of the Spikevax Covid-19 ...
pharmaphorum1d
BioNTech cancer vaccine hits the spot in melanoma
mRNA-4157 is a personalised vaccine targeting 34 cancer neoantigens, derived from a biopsy of a patient's tumour. In June, Moderna and MSD said they may be able to move ahead with regulatory ...
pharmaphorum3d
Merck gets on board with Moderna cancer vaccine in $250m deal
Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...
STAT6d
The view from overseas on tumult in U.S. science
Revenue was 4% higher than forecasts, mostly due to higher than expected sales of Moderna’s Covid vaccine, SpikeVax. In January, the company cut its sales guidance for 2025 by $1 billion to $1.5 ...
STAT6d
U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading statements to the public about their Covid-19 vaccines. And the move comes ...
Reuters6d
Moderna Inc
US gives conditional nod to Zoetis' bird flu vaccine for poultry Healthcare & Pharmaceuticalscategory· February 14, 2025 Moderna said on Friday that the U.S. FDA paused a late-stage trial of its ...
Detroit News6d
Red Wings sitting in good spot, but daunting schedule beckons
The Red Wings, except for Dylan Larkin (Team USA ... The Wings are 15-5-1 under McLellan and have taken over a wild-card playoff spot. Nobody saw this coming. "The spirit and the belief system ...